Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
62.11%
Operating Margin
58.33%
Net Margin
26.15%
Efficiency Metrics
Revenue per Expense Ratio
2.38
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
58.33%
Income Tax Rate
0.88%
EPS
3.7300000000
Balance Sheet Analysis
Current Ratio
0.65
Cash Ratio
0.62
Working Capital
$-149.59M
Debt to Equity
0.75
Debt to Assets
39.59%
Equity Ratio
53.08%
Cash Flow Analysis
Operating Cash Flow Ratio
51.55%
Free Cash Flow Ratio
24.90%
CapEx to Revenue
26.65%
Dividends Paid
$434.88M
Stock Buybacks
No buybacks
Total Shareholder Returns
$434.88M
Cash Position Change
1,437.1%
Key Takeaways (2023 FY)
Increased dividend payments by 8.53%
Detailed Growth Metrics
Core Performance
Revenue
8.38%
Net Income
-38.30%
EPS
-38.55%
Operating Income
236.42%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
3.46%
Operating Cash Flow
6.75%
Free Cash Flow
30.05%
Balance Sheet Health
Assets
0.60%
Debt
0.94%
Book Value per Share
-1.07%
Inventory
0.00%
Shareholder Returns
Dividends per Share
8.53%
Shares Outstanding
0.97%
Long Term Trends
3Y Revenue/Share
35.13%
5Y Revenue/Share
41.56%
3Y Dividend/Share
19.32%
5Y Dividend/Share
27.87%